Skip to main content

Table 3 Univariate regression models of TP, albumin, LDH, CRP, ESR, NLR, PLR, B-symptomatology, “bulky” tumor mass, mediastinal involvement by tumor mass and ECOG PS

From: Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Variable p OR 95% CI for OR
TP 0.026 1.91 1.08–3.39
Albumin 0.036 2.16 1.05–4.46
LDH 0.001 2.368 1.404–3.995
CRP 0.008 2.75 1.29–5.84
ESR 0.18 1.76 0.78–4.02
NLR 0.001 2.5 1.48–4.21
PLR 0.003 2.24 1.31–3.83
B-symptomatology 0.001 2.64 1.49–4.67
“Bulky” tumor mass 0.001 2.43 1.47–4.01
Mediastinal involvement 0.005 2.05 1.24–3.39
ECOG PS 0.015 1.99 1.14–3.5
  1. Legend: OR odds ratio, CI confidence interval, TP total proteins, LDH lactate dehydrogenase, CRP C-reactive protein, ESR erythrocyte sedimentation rate, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, ECOG PS Eastern Oncology Cooperative Group Performance Status